Company AngioDynamics, Inc.

Equities

ANGO

US03475V1017

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:30:00 2024-03-18 pm EDT 5-day change 1st Jan Change
5.39 USD +0.37% Intraday chart for AngioDynamics, Inc. -1.46% -31.25%

Business Summary

AngioDynamics, Inc. is a medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options. It is engaged in manufacturing, developing, and selling medical devices for vascular access, peripheral vascular disease, and oncology on a global basis. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, midlines, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and 400 Micron Perforator & Accessory Vein Ablation Kit (PVAK). Its vascular interventions include Syntrax Support Catheter, AlphaVac, SpeedLyser PRO Infusion System. Its ports include Xcela Plus Ports and Conventional Ports.

Number of employees: 815

Sales per Business

USD in Million2022Weight2023Weight Delta
Med Device
71.5 %
- - 242 71.5 % -
Med Tech
28.5 %
- - 97 28.5 % -

Sales per region

USD in Million2022Weight2023Weight Delta
United States
83.5 %
266 84.1 % 283 83.5 % +6.30%
International
16.5 %
50 15.9 % 56 16.5 % +11.51%

Managers

Managers TitleAgeSince
Chief Executive Officer 60 16-03-31
Director of Finance/CFO 49 08-05-31
Chief Tech/Sci/R&D Officer - 16-12-31
Chief Tech/Sci/R&D Officer 57 11-08-31
Corporate Officer/Principal - -
Corporate Officer/Principal 55 -
Human Resources Officer 57 19-08-31
Corporate Officer/Principal - -
Corporate Officer/Principal 59 15-02-28
General Counsel 55 17-03-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 63 16-11-08
Chairman 63 04-02-29
Director/Board Member 65 07-01-28
Director/Board Member 61 16-11-08
Chief Executive Officer 60 16-03-31
Director/Board Member 55 19-10-14
Director/Board Member 64 19-07-16
Director/Board Member 61 23-07-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 40,225,191 37,782,571 ( 93.93 %) 370,000 ( 0.9198 %) 93.93 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
11.82 %
4,712,616 11.82 % 26 M $
Vanguard Fiduciary Trust Co.
5.692 %
2,268,461 5.692 % 12 M $
Systematic Financial Management LP
4.848 %
1,932,154 4.848 % 11 M $
Morgan Stanley Investment Management, Inc.
4.733 %
1,886,200 4.733 % 10 M $
Millennium Management LLC
4.606 %
1,835,777 4.606 % 10 M $
Dimensional Fund Advisors LP
3.736 %
1,489,108 3.736 % 8 M $
Assenagon Asset Management SA
2.645 %
1,054,022 2.645 % 6 M $
Citadel Securities GP LLC
2.544 %
1,013,776 2.544 % 6 M $
1,009,307 2.532 % 6 M $
Acadian Asset Management LLC
2.269 %
904,422 2.269 % 5 M $

Company contact information

AngioDynamics, Inc.

14 Plaza Drive

12110, Latham

+518 795 1400

http://www.angiodynamics.com
address AngioDynamics, Inc.(ANGO)